Does the Mediterranean Diet Decrease Risk of Breast Cancer?
This study by van den Brandt and Schulpen (Cancer Epidemiology, 2017) sought to determine if adherence to the Mediterranean diet decreases risk of breast cancer.
Cohort Study and Meta-Analysis
Standardized Mediterranean Diet Score protocols were used to determine conformity with diet. Alcohol was not included in the score as is typically done because it is a known risk factor for breast cancer. 62,573 women aged 55-69 were surveyed for lifestyle and cancer incidence over the course of 20.3 years. 2,321 breast cancer cases and 1,655 subcohort members with complete data on diet and potential confounders were analyzed. The Mediterranean diet decreased the risk of ER (receptor) negative breast cancer with a Hazard Ratio of 0.60, but did not significantly decrease risk of ER positive or total breast cancer risk. Adherence to the Mediterranean diet could be used as an approach to prevent ER negative breast cancer.
Please log in to access ObGFirst and the 2T US Atlas
Media - Internet
Computer System Requirements
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan